2016 - Contraceptive Technology Boston

What's in the Pipeline? Contraceptive Options in Development (Rx = .5 hr.)

Apr 27, 2016 10:45am ‐ Apr 27, 2016 11:15am

Expiration Date: May 12, 2019


Credits: None available.

Standard: $12.00

Description

Learning Objectives:

  • List the new developments in long acting reversible methods
  • Describe the new combined hormonal and barrier methods under development
  • Explain how these new methods may help reduce unintended pregnancies

Speaker(s):

Disclosures

  • Anita Nelson, MD:

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck, NIH
    Allergan, Agile, Aspen Pharma, Bayer, Merck
    Allergan, Agile, Bayer, ContraMed
    Female Health, Merck, MicroCHIPS Biotech
    PharmaNest

    Relationship:

    Research (Grants)
    Speakers Bureau/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria

Credits

  • 0.50 - Pharmacology
  • 1.00 - Physician
  • 1.00 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.00 - CA RN/CA BRN

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content